Bictegravir/emtricitabine/tenofovir alafenamide shows favorable lipid and renal changes versus other regimens in treatment-experienced HIV-1 patients
New review shows a specific HIV drug combo may improve cholesterol and kidney health
This systematic literature review and network meta-analysis evaluates bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) against othe…
A large review found that a specific HIV drug combination improved cholesterol and kidney function compared to other common treatments for e…
